<DOC>
	<DOCNO>NCT01747941</DOCNO>
	<brief_summary>The study design test safety tolerability PK single oral ascend dos PF-06305591 ,</brief_summary>
	<brief_title>Study Investigate Safety , Tolerability , Pharmacokinetics PF-06305591 Healthy Male Female Subjects</brief_title>
	<detailed_description />
	<criteria>healthy young subject age 1855 Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Pregnant nursing female ; female childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>